학술논문
A randomized, multicenter, phase 2 trial comparing CAPTEM versus FOLFIRI as second-line treatment for MGMT-methylated, RAS-mutated metastatic colorectal cancer patients
Document Type
Article
Author
Pietrantonio, F.; Lobefaro, R.; Antista, M.; Miceli, R.; Raimondi, A.; de Braud, F.; Lonardi, S.; Rimassa, L.; Saggio, S.; Capone, I.; Milione, M.; Farina, G.; Longarini, R.; Mosconi, S.; Bianchi, A.S.; Tomasello, G.; Petrelli, F.; Murgioni, S.; Perrone, F.; Barault, L.; Nicolantonio, F.D.; Bartolomeo, M.D.
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology . (Annals of oncology : official journal of the European Society for Medical Oncology, 1 July 2019, 30:iv135)
Subject
Language
English
ISSN
15698041